The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 a (EF1a), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination.
INTRODUCTION
Sensory experience, learning, and neuronal activity stabilize or eliminate select excitatory synapses and sculpt the mature neuronal circuits that mediate sensory processing and memory (Xu et al., 2009; Yang et al., 2009 ). The cellular mechanisms that underlie activity or experience-dependent synapse elimination in the central nervous system are largely unknown. The discovery that activation of the myocyte enhancer factor 2 (MEF2) family of transcription factors suppresses synapse number provides an important molecular link to understand how neuronal activity leads to synapse elimination (Flavell et al., 2006; Pfeiffer et al., 2010; Tian et al., 2010) . MEF2 is activated upon neuronal depolarization and calcium influx, which induces the expression of MEF2 target genes that are thought to lead to synapse elimination (Flavell et al., 2006 McKinsey et al., 2002; Pulipparacharuvil et al., 2008) . The identity of the MEF2 target genes that promote synapse elimination or their mechanisms of action in synapse elimination is unknown. We recently demonstrated that MEF2-induced synapse elimination requires fragile X mental retardation protein (FMRP) (Pfeiffer et al., 2010) , an RNA-binding protein that regulates translation of its target mRNAs (Bassell and Warren, 2008) . FMRP is encoded by the Fmr1 gene, which is transcriptionally silenced in patients with fragile X syndrome (FXS), the most common inherited form of intellectual disability and autism (Abrahams and Geschwind, 2008; Kelleher and Bear, 2008) . In neurons of the mouse model of FXS, Fmr1 knockout (KO), MEF2-triggered synapse elimination is absent (Pfeiffer et al., 2010) , which may contribute to the observed excess of dendritic spines on cortical neurons of FXS patients and the Fmr1 KO mouse (Bagni and Greenough, 2005) . The mechanisms that underlie the deficiencies in synapse elimination associated with FXS are unknown. Our previous results indicated that FMRP functions downstream of MEF2-induced transcription to eliminate synapses (Pfeiffer et al., 2010) . Based on the known function of FMRP, we hypothesized that FMRP regulated translation of MEF2-generated transcripts.
To identify candidate transcripts involved in synapse elimination, we compared the known MEF2 target genes with FMRP-interacting mRNAs (Darnell et al., 2011) . Of the many common MEF2-and FMRP-interacting transcripts, we focused on protocadherin 10 (Pcdh10), also known as OL-protocadherin, a member of the cadherin superfamily of calcium-dependent cell adhesion molecules (Morishita and Yagi, 2007) . Importantly, homologous deletion of Pcdh10 in humans is associated with autism (Morrow et al., 2008) . Pcdh10 and other family members of the d2 nonclustered protocadherin family (Pcdh8 and 19) demonstrate weak homophilic binding activity relative to the classical cadherins (Hirano et al., 1999) . Furthermore, the diverse structure of protocadherins' cytoplasmic C termini is consistent with the multifunctional roles of protocadherins in cell signaling and function, in addition to cell adhesion Yasuda et al., 2007) . Pcdh10 is primarily expressed in the brain (Hirano et al., 1999) , where it is required for the growth of striatal axons and patterning of thalamocortical and corticothalamic projections during embryonic development (Uemura et al., 2007) . Interestingly, Pcdh10 is highly expressed in mature cortical neurons, where nothing is known of its function .
Here, we demonstrate that Pcdh10 is required for MEF2-induced synapse elimination and functions to deliver ubiquitinated postsynaptic density protein 95 (PSD-95), a critical synaptic scaffolding molecule to the proteasome. Fmr1 KO neurons have deficits in ubiquitination and degradation of PSD-95, and we uncover the molecular basis of this defect. Our results reveal mechanisms by which the activity-dependent transcription factor MEF2 refines synaptic connections in wild-type neurons and identify the mechanisms that underlie abnormal synapse refinement in fragile X syndrome. Importantly, this work demonstrates the necessity and distinct cellular functions of three genes linked to autism in the same synapse elimination process (Pcdh10, Fmr1. and Mef2; Novara et al., 2010) and thus provides evidence for a common synaptic deficit among different genetic causes of autism.
RESULTS

MEF2 and FMRP Regulate Pcdh10 Expression in Dendrites
To study the role of Pcdh10 in MEF2 and FMRP regulation of synapse number, we first validated the association of FMRP and Pcdh10 mRNA (Darnell et al., 2011) . We performed an RNA immunoprecipitation with an anti-FMRP antibody and pulled down Pcdh10 mRNA from hippocampal lysates of wildtype (WT) mice, but not Fmr1 KO mice ( Figure 1A ), providing evidence for Pcdh10 as an mRNA target of FMRP. We next examined whether Pcdh10 expression is regulated by MEF2 and FMRP, using lentivirus to transfect tamoxifen-inducible, constitutively active MEF2 (MEF2-VP16ERtm) (Flavell et al., 2006; Pfeiffer et al., 2010) into dissociated cortical neuron cultures, which are amenable to biochemical assays. Basal levels of Pcdh10 mRNA and another MEF2 target gene Nurr77 were not different between WT and Fmr1 KO neurons (vehicle; white bars, Figure 1B ). After 6 hr of 4-hydroxytamoxifen (tamoxifen, 1 mm) treatment, which induces translocation of MEF2-VP16ERtm to the nucleus to activate target genes (Flavell et al., 2006) , both Pcdh10 and Nurr77 mRNAs were elevated in WT and Fmr1 KO neurons (black bars, Figure 1B ), indicating that FMRP is not required for MEF2-induced transcription of target genes. Surprisingly, the level of Pcdh10 mRNA induced with MEF2 activation in Fmr1 KO neurons was greater than in WT neurons, perhaps reflecting a role of FMRP in RNA stability (Zhang et al., 2007) . In contrast, Pcdh10 protein is basally higher in Fmr1 KO neurons and is unresponsive to MEF2 activation (Figure 1C) . Similar to cultured neurons, Pcdh10 protein is elevated in hippocampal lysates of Fmr1 KO mice ( Figures 1D and S1A ).
One function of FMRP is to suppress translation of its mRNA targets (Darnell et al., 2011; Napoli et al., 2008) , suggesting that elevated Pcdh10 in Fmr1 KO neurons is due to increased translation rate. To test this possibility, we performed metabolic labeling under basal and MEF2 activated conditions. 35 S-Met/ Cys was added with vehicle or tamoxifen for 6 hr to MEF2-VP16ERtm-transfected cultures followed by immunoprecipitation of Pcdh10 or Tubulin (normalization control). We observed enhanced newly synthesized Pcdh10 in WT neurons upon tamoxifen treatment ( Figure 1E ). In Fmr1 KO neurons, basal translation rates of Pcdh10 were elevated and MEF2 activation failed to further increase Pcdh10 synthesis. To determine whether MEF2 regulates the half-life of Pcdh10, we applied a 2 hr pulse of 35 S-Met/Cys label to neuronal cultures and chased this with fresh medium containing vehicle or tamoxifen for the time points indicated in Figure 1F . The half-life of Pcdh10 was not affected by genotype or MEF2 activation (Figure 1F) . This data indicates that the elevated basal levels of Pcdh10 in Fmr1 KO neurons are due to elevated protein synthesis rates and not reduced turnover.
To determine whether dendritic Pcdh10 protein levels are elevated in Fmr1 KO neurons and to assess the cell autonomous role of FMRP in regulation of Pcdh10, we performed immunohistochemistry for Pcdh10 and microtubule-associated protein 2 (MAP2), a dendritic marker, in dissociated neuron cultures prepared from GFP/Fmr1 mosaic mice (i.e., GFP+ cells are ''wild type'' and GFPÀ cells are Fmr1 KO; see Extended Experimental Procedures available online). Immunohistochemistry confirmed that FMRP and GFP are coexpressed in hippocampal and cortical neurons of GFP/Fmr1 mosaic mice (Niere et al., 2012) (Figure S1B ). Pcdh10, but not MAP2, were elevated in both the soma and dendrites of Fmr1 KO neurons ( Figure 1G ) in comparison to neighboring GFP+, WT neurons. These results support a role for FMRP in translational suppression of Pcdh10, which leads to elevated Pcdh10 in Fmr1 KO neurons.
Immunohistochemistry for Pcdh10 in WT cultures revealed that Pcdh10 was present in dendritic spines where PSD-95, the postsynaptic excitatory synapse marker, was also enriched ( Figure 1H ). To validate the specificity of the antibody used for immunohistochemistry, we performed staining on hippocampal neurons transfected with two independent shRNAs against Pcdh10 ( Figure S1C) . The results showed similar knockdown efficiency (>50%) by shRNAs as observed with western blot ( Figures 3F and S3B ), validating the fluorescence signal of Pcdh10 seen in Figure 1H . Therefore, Pcdh10 is present in spines at the site of excitatory synapses and may function in MEF2 regulation of excitatory synapse number.
Pcdh10 Is Required for MEF2-Induced Synapse Elimination Because the expression of Pcdh10 is regulated by both MEF2 and FMRP, we hypothesized that Pcdh10 is required for MEF2-and FMRP-dependent synapse elimination (Pfeiffer et al., 2010) . We first determined whether manipulation of Pcdh10 alone was sufficient to affect excitatory synaptic transmission. To do this, we overexpressed mouse Pcdh10 in WT organotypic hippocampal slice cultures using biolistic transfection ( Figures S2A and S2B ) (Pfeiffer et al., 2010) . At 16-30 hr after transfection, we performed simultaneous whole-cell patch clamp recordings from Pcdh10-transfected and neighboring untransfected CA1 pyramidal neurons. Pcdh10 overexpression had no effect on excitatory synaptic transmission, as measured by the frequency or amplitude of miniature (m) EPSCs or evoked EPSC amplitude ( Figure S2B and Table S1 ). Similarly, there was no effect of Pcdh10 on paired-pulse facilitation (PPF) of evoked EPSCs, an indicator of presynaptic release probability (Table  S1 ). In the converse experiment, we knocked down endogenous Pcdh10 in WT hippocampal slice cultures using either one of two shRNAs targeting different regions of Pcdh10 mRNA. After 40-60 hr transfection, neither shRNA against Pcdh10 nor a control nontarget shRNA had any effect on the aforementioned measurements of excitatory synaptic function ( Figures S2C,   S2D , and S2E and Table S1 ). Similarly, transfection of dissociated hippocampal cultures with either Flag-Pcdh10 or shRNA against Pcdh10 ( Figures S2F and S2G ) had no effect on synapse number, as measured by coclusters of the pre-and postsynaptic proteins synapsin-1 and PSD-95, or PSD-95 puncta number and size. These results indicate that acute changes in Pcdh10 levels are not sufficient to affect excitatory synaptic function.
To test whether Pcdh10 is required for MEF2-induced synapse elimination, we cotransfected WT hippocampal slice cultures with plasmids generating either one of two shRNAs against Pcdh10 together with MEF2-VP16ERtm. Sister cultures were cotransfected with a control shRNA together with MEF2-VP16ERtm. After 24 hr, tamoxifen was applied to the slices to activate MEF2 for another 16-32 hr, followed by simultaneous recordings of transfected and neighboring untransfected CA1 neurons. As shown, neurons transfected with MEF2-VP16ERtm and control shRNA had a decrease in mEPSC frequency and evoked EPSC amplitude but no change in PPF ( Figure 2A and Table S1 ). These changes are consistent and correlate with structural synapse elimination that we previously demonstrated with MEF2-VP16ERtm in this preparation (Flavell et al., 2006; Pfeiffer et al., 2010) . However, MEF2-induced functional synapse elimination was blocked in neurons transfected with shRNA against Pcdh10 (Figures 2B and S2H and Table S1 ) and rescued by cotransfection of a shRNA-insensitive Pcdh10 ( Figure 2C and Table S1 ) together with the Pcdh10 shRNA.
shRNA-mediated knockdown of Pcdh10 did not affect MEF2-induced transcription of Nurr77 as measured with real-time RT-PCR ( Figure S2I ), suggesting that Pcdh10 functions in synapse elimination downstream of MEF2 activated transcription.
MEF2 Induces Pcdh10-Dependent Degradation of PSD-95
To determine the cellular mechanism by which Pcdh10 mediates MEF2-induced synapse elimination, we turned to dissociated cortical neuron cultures, which are amenable to biochemical methods. We hypothesized that MEF2 activation causes rapid Figure S2 and Table S1 .
synapse elimination by the regulated degradation of synaptic scaffolding proteins. To investigate this possibility, we monitored the level of several postsynaptic scaffolding proteins in MEF2-VP16ERtm transfected cortical neuron cultures after 6 hr of tamoxifen treatment. As shown in Figure 3A , PSD-95 levels were significantly decreased in WT neurons, whereas other synaptic proteins (mGluR5, Homer, and CaMKIIa) remained unchanged. Consistent with the deficit in MEF2-induced synapse elimination in Fmr1 KO neurons, PSD-95 levels were unchanged upon MEF2 activation in Fmr1 KO neurons. Similar results were observed with immunohistochemistry for PSD-95 in dissociated hippocampal neurons ( Figure 3B ). This result also suggests that the downregulation of PSD-95 is a common consequence of MEF2 activation in both cortical and hippocampal neurons.
To determine whether the downregulation of PSD-95 resulted from reduced synthesis or increased degradation, we performed metabolic labeling with 35 S-Met/Cys in dissociated cortical neuron cultures. After 6 hr of MEF2 activation and 35 S-Met/Cys label, there was no change in newly synthesized PSD-95 from either WT or Fmr1 KO neurons ( Figure 3C ). However, using the pulse-chase 35 S-Met/Cys labeling assay, the half-life of PSD-95 was reduced by $35% after MEF2 activation in WT neurons ( Figure 3D ). Like PSD-95 protein levels ( Figures 3A  and 3B ), PSD-95 half-life was unaffected by MEF2 activation in Fmr1 KO neurons. To investigate whether MEF2-induced degradation of PSD-95 in WT neurons is proteasome dependent, we applied proteasome inhibitors MG132 (5 mM) or lactacystin (5 mM), together with tamoxifen ( Figures 3E and S3A ). Both MG132 and lactacystin blocked MEF2-induced downregulation of PSD-95 in WT neurons, and no changes in PSD-95 were observed under any condition in Fmr1 KO neurons.
To determine whether MEF2-induced degradation of PSD-95 is mediated by Pcdh10, we used lentivirus to deliver MEF2-VP16ERtm along with one of two different shRNAs against Pcdh10 into dissociated cortical neuron cultures. Knocking down Pcdh10 with either shRNA inhibited MEF2-induced PSD-95 degradation ( Figures 3F and S3B ). PSD-95 degradation is rescued by lentiviral coexpression of shRNA-insensitive Pcdh10 together with the Pcdh10 shRNA ( Figure S3C ). These findings indicate that Pcdh10 is required for MEF2-induced degradation of PSD-95 and suggest a molecular mechanism for Pcdh10 in MEF2-induced synapse elimination.
Pcdh10 Facilitates the Proteasomal Deposition of Ubiquitinated PSD-95
To better determine the role of Pcdh10 in MEF2-induced regulation of PSD-95, we investigated whether Pcdh10 physically associated with PSD-95 and whether this changed with MEF2 activation. Using coimmunoprecipitation of Pcdh10 with PSD-95 from cortical neuron cultures (in the presence of MG132), we found that Pcdh10 could associate with PSD-95 ( Figure 4A ). Activation of MEF2 for 6 hr drastically increased the association between Pcdh10 and PSD-95 in WT neurons, but not in Fmr1 KO neurons ( Figure 4A ). Similar results were obtained in hippocampal neuron cultures ( Figure S4A ). Given that MEF2 increases the expression of Pcdh10 in WT cultures ( Figure 1D ), we considered whether the MEF2-induced association of Pcdh10 and PSD-95 is due to enhanced production of Pcdh10. We used lentivirus to transfect WT or Fmr1 KO cortical cultures with a Flag-tagged Pcdh10 driven by the cytomegalovirus (CMV) promoter whose transcription is not regulated by MEF2. Although total Flag-Pcdh10 levels were unchanged upon MEF2 activation, immunoprecipitation of PSD-95 revealed an increase in Flag-Pcdh10 association with PSD-95 ( Figure 4B , in the presence of MG132). This suggests that MEF2 promotes the association of Pcdh10 with PSD-95 independent of regulating Pcdh10 levels. In Fmr1 KO cultures, MEF2 activation did not stimulate an interaction of PSD-95 with Flag-Pcdh10, suggesting that the deficit in PSD95 degradation in Fmr1 KO neurons is not due to the lack of MEF2-triggered Pcdh10 translation but instead on a distinct function of FMRP.
To determine the mechanism by which Pcdh10 regulates MEF2-dependent PSD-95 proteasomal degradation, we examined ubiquitination of PSD-95. MEF2 activation in WT cultures resulted in PSD-95 ubiquitination, as observed by immunoprecipitation of PSD-95 followed by western blotting with an antiubiquitin (Ub) antibody (in the presence of MG132, Figure 4C , top). Similar to previous reports (Colledge et al., 2003; Rezvani et al., 2007) , polyubiquitinated PSD-95 was observed as multiple, distinct high-molecular-weight bands (115-200 kDa). Knockdown of Pcdh10 with a lentiviral-expressed shRNA had a slight effect on MEF2-induced PSD-95 ubiquitination. However, using GST-Ubl (ubiquitin-like domain from Rad23) (Bingol et al., 2010) to pull down the proteasome and proteasome-interacting proteins (in the presence of MG132), we could only detect ubiquitinated PSD-95 in neurons transfected with MEF2 plus control shRNA, but not Pcdh10 shRNA ( Figure 4C , second panel from the top, and S4B). These results suggest that the predominant role of Pcdh10 is to associate ubiquitinated PSD-95 with the proteasome.
Because Pcdh10 is important for association of ubiquitinated PSD-95 with the proteasome, we next asked whether PSD-95 ubiquitination or proteasome association is deficient in Fmr1 KO neurons. In contrast to WT cultures, MEF2 activation in Fmr1 KO cultures failed to increase PSD-95 ubiquitination (Figure 4C) . Consistent with these results, basal ubiquitination of PSD-95 is reduced in vivo in Fmr1 KO hippocampi ( Figure S4C ). Taken together, these findings suggest that FMRP and Pcdh10 have distinct roles in MEF2-induced PSD-95 degradation: (1) FMRP is required for MEF2-induced ubiquitination of PSD-95, and (2) Pcdh10 is primarily required for linking ubiquitinated PSD-95 to the proteasomal machinery.
Based on results in WT cultures, we hypothesize that Pcdh10 associates ubiquitinated PSD-95 with the proteasome. To test this idea, we determined whether Pcdh10 interacts with ubiquitinated PSD-95 in vitro. We prepared native and ubiquitinated GST-PSD-95 by in vitro ubiquitination and observed that Pcdh10 from WT brain lysates preferentially interacts with ubiquitinated, but not native, GST-PSD-95 ( Figure 4D ). Ubiquitinated GST-PSD-95 failed to interact with in-vitro-translated Pcdh10 ( Figure S4D ), suggesting that posttranslational modifications of Pcdh10 or other interacting proteins are necessary. To test whether Pcdh10 interacts with the proteasome, we used GST-Ubl to pull down the proteasome and find that Pcdh10, the proteasome component Rpt1 (Demartino and Gillette, 2007) , and the proteasome-interacting protein CaMKIIa (Bingol et al., 2010) were pulled down from both WT and Fmr1 KO mouse brain ( Figure 4E ). In contrast, another protocadherind family member, Pcdh9 (Morishita and Yagi, 2007) , was not pulled down by GST-Ubl. The interaction of Pcdh10 and the proteasome was also confirmed by the demonstration that the GST-tagged C terminus of Pcdh10 interacts with a purified proteasome preparation from Flag-Rpt6 stably expressing HEK293 cells (Kim and DeMartino, 2011) (Figures 4F and S4E ). Together, these results suggest that Pcdh10 interacts with ubiquitinated PSD-95 and the proteasome, and this interaction may not be conserved in other protocadherin family members.
We next determined whether MEF2-induced PSD-95 degradation and synapse elimination required Pcdh10 association with the proteasome. Toward this goal, we first mapped the minimum region of Pcdh10 that is required for interaction with the proteasome. We focused on the C terminus of Pcdh10 (266 amino acid) because it is predicted to be a cytoplasmic domain (Morishita and Yagi, 2007) . We made various deletion constructs of the C terminus of Pcdh10 tagged with GST and tested their ability to pull down proteasomal complexes from brain lysates, as determined by association with the essential proteasome protein component Rpt1 (Bingol et al., 2010) (Figure 5A) . Using this assay, we identified a 102 amino acid region (amino acids 778-879) of Pcdh10 required for the interaction with the proteasome. Amino acids 778-879 are highly conserved in Pcdh10 across species ( Figure S5A ), and we termed this sequence the proteasome interacting region (PIR).
We aimed to determine whether Pcdh10 association with the proteasome is necessary for MEF2-induced PSD-95 degradation and synapse elimination. In preparation for these experiments, we expressed a Flag-tagged PIR in WT cultured neurons and found that it distributes in dendrites and spines but did not alter general proteasome activity ( Figures S5B and S5C) . Importantly, Flag-PIR expression effectively competed with Pcdh10 and greatly reduced the association of endogenous Pcdh10 with the proteasome in neurons, as assessed by GST-Ubl pull-down ( Figure 5B ). Coexpression of Flag-PIR and MEF2-VP16ERtm in WT cortical neuron cultures blocked MEF2-induced degradation of PSD-95 ( Figure 5C ). Similarly, biolistic cotransfection of Flag-PIR and MEF2-VP16 into CA1 neurons of WT mouse hippocampal slice cultures blocked MEF2-induced functional synapse elimination ( Figures 5D and 5E and Table S1 ) and MEF2-induced reduction in dendritic spine density (Figure 5F ). Expression of Flag-PIR alone did not alter synaptic function ( Figure S5D ), spine density ( Figure 5F ), or MEF2-induced transcription ( Figure S2I ). These data demonstrate that Pcdh10 association with the proteasome is necessary for MEF2-induced PSD-95 degradation, as well as functional and structural synapse elimination. And based on these and our biochemical data (Figure 4) , we propose that one role of Pcdh10 in synapse elimination is to deliver ubiquitinated PSD-95 to the proteasome for degradation.
The Ubiquitin E3 Ligase for PSD-95, Mdm2, Is Dysregulated in Fmr1 KO Neurons In Fmr1 KO neurons, MEF2-induced ubiquitination of PSD-95 is absent; a process that is independent of Pcdh10. To investigate the deficit in PSD-95 ubiquitination in Fmr1 KO neurons, we examined the substrate-specific step of the ubiquitination process, which involves the ubiquitin E3 ligase for PSD-95, murine double minute 2 (Mdm2) (Colledge et al., 2003) . Using shRNAs against Mdm2, we observed that Mdm2 is required for MEF2-induced PSD-95 ubiquitination ( Figure 6A ) and degradation ( Figures 6B, S6A , S6B, and S6C) in WT cortical neurons, thus confirming that Mdm2 is the relevant E3 ligase for PSD-95. To investigate whether Mdm2 is dysregulated in Fmr1 KO neurons, we performed coimmunoprecipitation and observed reduced interaction of Mdm2 and PSD-95 in Fmr1 KO hippocampus in contrast to WT hippocampus ( Figure 6C ). Using immunohistochemistry for Mdm2 in dissociated hippocampal neurons, we also observed lower colocalization of Mdm2 with PSD-95 in dendrites of Fmr1 KO neurons compared to WT neurons ( Figure 6D ). Although total Mdm2 levels were normal in Fmr1 KO hippocampus ( Figure 6C ), Mdm2 levels in synaptoneurosome fractions of Fmr1 KO hippocampi were reduced to about 40% of WT levels ( Figure 6E ). We hypothesized that MEF2 may enhance the synaptic localization of Mdm2, and this may be deficient in Fmr1 KO neurons. To test this possibility, we activated MEF2 in dissociated cortical neuron cultures and examined Mdm2 levels in synaptoneurosome fractions and in coimmunoprecipitates with PSD-95. In WT neurons, MEF2 activation increased Mdm2 levels in synaptoneurosomes (Figure 6F) , as well as the interaction between PSD-95 and Mdm2 ( Figure 6G ). In contrast, in Fmr1 KO neurons, MEF2 failed to increase Mdm2 levels in synaptoneurosomes or the association of Mdm2 with PSD-95. MEF2 activation did not alter total Mdm2 levels in either WT or Fmr1 KO cultures ( Figures 6B and 6F) . Together, these results indicate that MEF2 stimulates the localization of Mdm2 to the synaptic compartment and to PSD-95, and this process is defective in Fmr1 KO neurons.
Elevated EF1a Inhibits Mdm2 from Interacting with PSD-95 in Fmr1 KO Neurons
In Fmr1 KO neurons, Mdm2 localization at the synapse is reduced, and MEF2-induced redistribution of Mdm2 to synapses is deficient (Figure 6 ). We hypothesized that Mdm2 may have an abnormal interactome in Fmr1 KO neurons. A previous proteomic study to identify human Mdm2 (Hdm2)-interacting proteins discovered a robust interaction of eukaryotic translation elongation factor 1-a (EF1a) and Hdm2 (Frum et al., 2007) . EF1a is an FMRP target mRNA, and EF1a protein levels are upregulated in Fmr1 KO brain (Darnell et al., 2011; Sung et al., 2003) . We hypothesized that elevated EF1a in Fmr1 KO neurons sequesters Mdm2 and prevents it from ubiquitinating PSD-95. In support of this hypothesis, immunoprecipitation of Mdm2 from hippocampal lysates revealed an increased interaction of EF1a and Mdm2 in vivo in Fmr1 KO mice ( Figure 7A ). This increased interaction may be due to the observed increase in total EF1a protein in Fmr1 KO ( Figure 7A ). To determine whether EF1a and PSD-95 directly compete for interactions with Mdm2, we obtained recombinant His-Mdm2, GST-EF1a, and GST-PSD-95. To Ni beads with bound His-Mdm2, we first added increasing amounts of GST-EF1a. After washing off unbound GST-EF1a, we incubated the complex with GST-PSD-95. Because a possible degraded product of His-Mdm2 runs at the same position of GST-EF1a on a SDS-PAGE, we used western blotting to detect the composition of the complex. As shown (Figure 7B) , the binding of Mdm2 to EF1a occurs with a stoichiometry of $1:1, and EF1a-bound Mdm2 lost the ability to bind PSD-95. His-Mdm2 also runs at a position approximately doubled to its predicted molecular weight, suggesting formation of homodimer (Dolezelova et al., 2012) . The GST tag does not interact with HisMdm2 nor interfere with the binding of His-Mdm2 to GST-EF1a or GST-PSD-95 ( Figure S7A ). To test the affinity of Mdm2 toward binding EF1a or PSD-95, we premixed GST-EF1a (1 pmol) and Error bars represent SEM. *p < 0.05, ***p < 0.001. See also Figure S5 and Table S1. GST-PSD-95 (1 pmol), followed by adding Ni beads with bound His-Mdm2 (0.5 pmol). As shown in Figure 7C , Mdm2 has higher affinity toward binding EF1a over PSD-95. Together, these results indicate that EF1a can effectively compete with PSD-95 for binding to Mdm2.
We hypothesized that reducing EF1a levels in Fmr1 KO neurons may release Mdm2, allow interactions with PSD-95, and rescue MEF2-induced PSD-95 degradation. To test this possibility, we applied a lentivirus expressing a shRNA against EF1a that reduced EF1a in Fmr1 KO neurons to WT levels but did not affect Pcdh10 protein levels ( Figure S7B ). Knocking down EF1a in Fmr1 KO neurons did not affect MEF2 activation ( Figure S7C ) but restored MEF2-induced synaptic localization of Mdm2 ( Figure 7D ) and the interaction between Mdm2 and PSD-95 ( Figure 7E ).
Knocking down EF1a also restored MEF2-induced PSD-95 degradation in Fmr1 KO neurons, which required Mdm2 (Figures 7F and S7D ). Coexpression of a shRNA-insensitive EF1a together with the EF1a shRNA inhibited MEF2-induced synaptic accumulation of Mdm2 (Figure S7E ), the interaction between PSD-95 and Mdm2 ( Figure S7F ), and PSD-95 degradation (Figure S7G) in Fmr1 KO neurons, demonstrating the specificity of the EF1a shRNA. These results demonstrate that elevated EF1a in Fmr1 KO neurons inhibits Mdm2 from interacting with PSD-95 and blocks the subsequent degradation of PSD-95.
To determine whether knocking down EF1a in Fmr1 KO neurons could also restore MEF2-induced synapse elimination, we biolistically transfected Fmr1 KO hippocampal slice cultures with a plasmid encoding a shRNA for EF1a or a control shRNA. Expression of either shRNA alone had no effect on synaptic function (Figures S7H and S7I and Table S1 ). We then cotransfected Fmr1 KO slice cultures with either control shRNA or EF1a shRNA together with MEF2-VP16ERtm and subsequently treated the cultures with tamoxifen. Fmr1 KO neurons transfected with control shRNA had a deficit in MEF2-induced functional synapse elimination ( Figure 7G ), consistent with our previous report (Pfeiffer et al., 2010) . As observed with PSD-95 degradation, EF1a shRNA transfection rescued robust functional synapse elimination in response to MEF2 activation (Figure 7H) . Again, coexpression of a shRNA-insensitive EF1a together with the EF1a shRNA blocked MEF2-induced functional synapse elimination ( Figure 7I ). The shRNA-insensitive EF1a on its own did not affect excitatory synaptic function ( Figure S7J ). Taken together, our results indicate that elevated EF1a in Fmr1 KO neurons inhibits Mdm2 from triggering PSD-95 degradation and subsequent synapse elimination by MEF2 in the Fmr1 KO neurons. By knocking down EF1a, we were able to rescue the following in response to MEF2 activation: (1) synaptic redistribution of Mdm2, (2) the interaction between Mdm2 and PSD-95, (3) PSD-95 degradation, and (4) synapse elimination.
DISCUSSION
MEF2 Triggers Synapse Elimination by Promoting Pcdh10-Dependent Degradation of a Synaptic Scaffolding Protein
Here we identified a mechanism by which the activity-dependent transcription factor, MEF2, promotes synapse elimination as well as the molecular basis of the deficit in synapse elimination observed in fragile X syndrome, a prevalent cognitive and autistic disorder. In wild-type neurons, MEF2 activation induces transcription of Pcdh10, which mediates degradation of the synaptic scaffold PSD-95, and synapse elimination by associating ubiquitinated PSD-95 with the proteasome ( Figure 7J ). Although translation of Pcdh10, an FMRP target mRNA, is dysregulated in Fmr1 KO neurons, we find a deficit in MEF2-stimulated ubiquitination of PSD-95, a step that is upstream and independent of Pcdh10. The deficit in PSD-95 ubiquitination in Fmr1 KO neurons is caused by elevated levels of EF1a protein, an FMRP target mRNA, which sequesters Mdm2 from the synapse and PSD-95 ( Figure 7J ). In support of this conclusion, knockdown of EF1a levels rescues MEF2-induced PSD-95 degradation and synapse elimination in Fmr1 KO neurons. Whether MEF2 regulates the interaction of EF1a and Mdm2 to regulate PSD-95 degradation in WT neurons is unknown.
Protocadherins and Synapse Elimination
The protocadherins are ancestors of the classical cadherins, the more well-known members of the Ca 2+ -dependent cell adhesion molecule family (Giagtzoglou et al., 2009) . Although the extracellular domains of protocadherins share homology with the traditional cadherins, they lack a hydrophobic pocket within extracellular domain 1 that is important for strong homophilic adhesion (Morishita et al., 2006; Morishita and Yagi, 2007) . Consistent with this prediction, Pcdh10, when expressed in cell lines, clusters at points of cell contact and stimulates cell aggregation but less robustly than classical cadherins (Hirano et al., 1999) . A recent study demonstrated that another d2 nonclustered protocadherin family member, Pcdh8 or Arcadlin, is induced in neurons in response to seizures and interacts in cis with N-cadherin (a classical cadherin) in postsynaptic membranes. Homophilic interactions of Pcdh8, in cis or trans, recruit p38 MAPK to its C terminus, which in turn, stimulates the coendocytosis of Pcdh8 and N-cadherin and decreases dendritic spine density (Yasuda et al., 2007) . An interesting possibility is that the induction of the d2 Pcdhs, such as Pcdh8 and Pcdh10, functions to increase the membrane concentration and probability of homophilic Pcdh interactions, which activates key signaling pathways and their endocytosis. Such endocytosis could facilitate interactions of Pcdh10 with ubiquitinated PSD-95 and the proteasome.
MEF2 Promotes Degradation of a Postsynaptic Scaffold to Eliminate Synapses
MEF2 activation is associated with a rapid reduction of synapse number, suggesting that MEF2 eliminates pre-existing synapses (Flavell et al., 2006; Pfeiffer et al., 2010) . However, MEF2 may also inhibit synapse formation rates. In support of an elimination mechanism, MEF2 activation caused a rapid and selective degradation of PSD-95 and a decrease in functional synapse number-effects that both required the MEF2 transcript, Pcdh10. Disrupting the association of Pcdh10 with the proteasome using the PIR peptide blocked MEF2-induced PSD-95 degradation, as well as functional and structural synapse elimination, suggesting that ubiquitination and Pcdh10-dependent degradation of PSD-95 are key steps that couple MEF2-driven transcription to synapse elimination. PSD-95 stabilizes synaptic AMPARs, increases synaptic function, and results in larger and more stable spines (Keith and El-Husseini, 2008; Opazo et al., 2011) . Conversely, reductions in PSD-95 can lead to diffusion and endocytosis of synaptic AMPARs, weaker synapses, smaller spines, and spine elimination (Colledge et al., 2003; Haas et al., 2007; Keith and El-Husseini, 2008; Opazo et al., 2011; Woods et al., 2011) . Specifically, in response to NMDAR activation, PSD-95 is ubiquitinated by Mdm2, degraded by the proteasome, removed from spines, and required for endocytosis of AMPARs (Colledge et al., 2003; Sturgill et al., 2009 ). Therefore, MEF2-triggered degradation of PSD-95 may cause destabilization and removal of synaptic AMPARs that precedes elimination of the structural synapse. Of note, knockdown of Pcdh10 prevented MEF2-induced functional synapse elimination, but not ubiquitination of PSD-95. This suggests that ubiquitination of PSD-95 is not sufficient to mediate functional synapse elimination, as Pcdh10-dependent targeting of ubiquitinated PSD-95 to the proteasome is also required.
Recapitulating Synapse Elimination in Fragile X Syndrome Fragile X syndrome patients and Fmr1 KO mice display elevated dendritic spine number in mature cortical neurons, which may contribute to the neuronal hyperexcitability, sensory hypersensitivity, and epileptic seizures observed in patients and the mouse model (Berry-Kravis, 2002; Dö len et al., 2010) . A deficit in activity and MEF2-dependent synapse elimination could lead to excess spines. In support of this idea, experience-dependent spine (legend continued on next page) elimination in the somatosensory barrel cortex is deficient in Fmr1 KO mice (Pan et al., 2010) . The molecular mechanisms that lead to elevated dendritic spine number or the deficits in synapse elimination associated with fragile X are unknown. Current evidence suggests that FMRP functions as a translational switch of its target mRNAs. At steady state, FMRP suppresses translation of its mRNA targets in dendrites, and it derepresses or stimulates their translation upon synaptic stimulation dephosphorylation and/or degradation (Bassell and Warren, 2008; Niere et al., 2012) . Consistent with this model, we observed elevated Pcdh10 translation rates in Fmr1 KO neurons that were not stimulated by MEF2 despite induction of Pcdh10 mRNA. Alternatively, Pcdh10 translation rates in Fmr1 KO neurons may be saturated and cannot be further increased by elevated mRNA. We would expect that translational control of other FMRP target mRNAs that are induced in response to MEF2 would be similarly affected in Fmr1 KO neurons.
Although translational control of Pcdh10 is abnormal in Fmr1 KO neurons, our results suggest that this does not underlie the deficit in MEF2-induced synapse elimination. Knocking down EF1a restores MEF2-induced synapse elimination in Fmr1 KO mice without affecting Pcdh10 protein levels. Therefore, one requirement of FMRP in MEF2-induced synapse elimination is to suppress steady-state translation of EF1a and allow appropriate MEF2-regulated synaptic targeting of Mdm2 and PSD-95 ubiquitination. This highlights the importance of translational suppression and regulation of protein concentration in dendrites for proper synaptic plasticity. Loss-of-function mutations in the MEF2 isoform, Mef2C, Fmr1, or Pcdh10 are all associated with autism, with or without intellectual disability (Abrahams and Geschwind, 2008; Morrow et al., 2008; Novara et al., 2010) . Here, we have described distinct roles for all three genes in regulated degradation of PSD-95 and synapse elimination. This work suggests a common deficit in activity-dependent synapse elimination among different genetic causes of autism.
EXPERIMENTAL PROCEDURES
Organotypic Slice Culture and Dissociated Neuron Culture Organotypic hippocampal slice cultures were made from postnatal day (P) 6-7 WT or Fmr1 KO mice bred from the congenic C57BL/6 mouse strain and transfected as described (Pfeiffer et al., 2010 ) (Extended Experimental Procedures). Dissociated hippocampal or cortical cultures were prepared from P0-1 WT and Fmr1 KO mice as described (Niere et al., 2012) .
Electrophysiology
Dual whole-cell patch recordings were obtained from CA1 pyramidal neurons in slice cultures using IR-DIC and GFP fluorescence to identify nontransfected and transfected neurons as described (Pfeiffer et al., 2010 ) (Extended Experimental Procedures).
Synaptoneurosome Preparation
Hippocampal synaptoneurosomes were prepared as previously described (Waung et al., 2008) . For synaptoneurosomes of dissociated cultures, cells were scraped off in buffer: 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 2.5 mM CaCl 2 , 1.53 mM KH 2 PO 4 , 212.7 mM glucose, 1 mM DTT (pH 7.4), and protease inhibitor cocktail (Calbiochem) followed by same procedures as described (Waung et al., 2008) .
Statistical Analysis
For multiple comparisons, two-way ANOVA and Bonferroni posthoc tests were performed. Paired t tests were used for electrophysiology assays. Independent t test was used for Figures 1D, 5B , 5F, 6C, and 7A. In all figures, error bars represent SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
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